Press "Enter" to skip to content

Second US lawsuit brought against Aurobindo Pharma

Aurobindo Pharma on Tuesday informed stock exchanges that the company, as well as other firms in the US generic drug industry, are facing a second lawsuit for violation of antitrust laws.

Original source:

Also Read:   U.S. FDA panel recommends approval of Johnson & Johnson's depression drug